RA
MDVL

Royce & Associates’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Royce & Associates’s Portfolio MDVL Stock Details MDVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,335
Closed -$1.43M – 1022
2021
Q2 		$1.43M Hold
2,335
– – 0.01% 807
2021
Q1 		$1.63M Buy
2,335
+1,282
+122% +$922K 0.01% 787
2020
Q4 		$792K Buy
+1,053
New +$736K 0.01% 840

Other funds holding MDVL

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
CI
Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Royce & Associates's MDVL Position: Q3 2021 in Review

Royce & Associates sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2021, closing a stake of 2,335 shares — an estimated $1.43M sold.

Royce & Associates first reported a position in MDVL in Q4 2020 and held it in 3 quarters. The position peaked at $1.63M in Q1 2021. 49 funds tracked by Wall St. Rank hold MDVL as of Q3 2021.

  • Royce & Associates reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Royce & Associates sold 2,335 MedAvail Holdings, Inc. Common Stock shares in Q3 2021, an estimated $1.43M.
  • Royce & Associates first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Royce & Associates's MedAvail Holdings, Inc. Common Stock position peaked at $1.63M in Q1 2021.
  • 49 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2021.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.